Lobbying

  • |

    When Power Has a Cover Charge

    ByPhil McCracken

    I followed the invoice into Washington’s VIP room, where a few lobbyists and big donors can treat public power like a discount membership club: campaign cash at the desk, favors in the coat check, and the pen available by appointment. The access economy calls this efficiency. That is a lovely word for keeping the customer list short.

    Millions of ordinary people are less convenient. They ask questions, remember promises, compare receipts, and refuse to fit neatly inside a catered meeting. Broad participation does not make corruption impossible, but it makes concentrated influence harder to purchase quietly and harder to disguise as public service. The money trail wore cologne until the whole country walked into the room. Suddenly, democracy had an invoice nobody could quietly expense.

  • |

    The Loophole Is Math Until the Lobbyist Gets the Bill

    ByPhil McCracken

    I followed the invoice, and it leads to carried interest: a tax preference that could be treated more like ordinary income, with a cited Yale Budget Lab estimate putting potential ten-year revenue at $87.7 billion. That is apparently when private equity lobbyists discover arithmetic is radical. Suddenly, investment, jobs, and billionaire geography are summoned like emergency witnesses.

    Ordinary people are routinely told the tax code is just math, especially when the bill lands on their kitchen table. But when the invoice reaches private equity, the calculator becomes a panic button. The argument is not necessarily that every warning is impossible; it is that a favored tax treatment gets dressed up as the load-bearing wall of the economy. Follow the invoice long enough and the outrage looks less like national peril than a class-specific billing dispute.

  • |

    The Drug-Price Mystery Has a Lobbying Budget

    ByPhil McCracken

    Patients receive a prescription bill written like a ransom note from an accountant, while the pharmaceutical industry’s Washington invoice arrives in plain English. Bloomberg Government reported that PhRMA spent $7.4 million lobbying in the second quarter of 2026, bringing its year-to-date total to $19.6 million. I have seen less money spent renovating an entire Capitol Hill office, although admittedly fewer people were trying to influence the rulebook.

    That spending does not, by itself, prove that lobbying caused any particular drug price or defeated any particular proposal. It does reveal something less mysterious: the trade group representing major pharmaceutical interests has a very clear budget for being present while everyone else debates why medicine costs so much. When an industry spends millions to participate in the policy conversation, “expertise” starts looking a lot like a reserved seat with better coffee.

    The timing is the whole money trail. Washington continued debating Medicare negotiation, most-favored-nation pricing, and other proposals aimed at lowering costs. Those are policy arguments, not settled outcomes, and they deserve scrutiny on their details. But patients are routinely told that drug pricing is too complex for ordinary people to understand, just as the people affected by the bill are asked to wait outside the room while well-funded representatives explain the machinery.

    That is the access economy in its natural habitat: the public gets a maze of rebates, formularies, negotiations, and carefully polished explanations; lobbyists get calendars, meetings, and a professional vocabulary for turning private interests into public homework. The pharmaceutical lobbying total reported by Bloomberg Government is not the entire industry’s spending, and it is not evidence of illegal conduct. It is simply a large, legible number attached to an argument that is often presented as impossibly complicated.

    So Washington keeps searching for the missing answer to drug prices. Meanwhile, the money trail has already found the billing department. Patients get the mystery, lobbyists get the appointment calendar, and taxpayers get another explanation for why reform remains under review.

    Sources

  • |

    Follow the Money: The “Suspicious Trading” Money Trail (Not a Legal Conclusion)

    ByPhil McCracken

    Here’s the “Suspicious Trading Money Trail” setup: in the second Trump administration timeline the poster is pointing at, policy timing and portfolio gains supposedly line up—Nvidia, Dell, Intel, Amazon, Microsoft, Vistra & Eaton, “625 ‘Unsolicited’ Trades,” and “Inflation / Fed Timing”—and then it waves a “Not a legal conclusion” receipt like that ends the conversation.

    The contradiction is the same every time: it’s marketed like a scandal-list pattern, but it’s protected like financial astrology. Voters aren’t asking for a legal conclusion—they’re asking for the receipts: disclosures, records, and daylight, because coincidence shouldn’t require a straight face.

  • |

    Drain the Swamp? Cool—Here’s Your Invoice

    ByPhil McCracken

    I file this under Lex Luthor government billing practices: STEP 1 is sue the taxpayers, taxpayers are on the hook, and the “big threat, big number” is a ten-billion-dollar lawsuit stapled to Trump Tower paperwork. Then Step 2 arrives with a straight face: call it “fiscal responsibility,” like the country just got a receipt for being wronged.

    Because the magic trick isn’t draining anything. It’s turning public money into private leverage and informing you—nicely—that you’re the payment method: taxpayer funds, paid for by you. He didn’t drain the swamp / He sent it an invoice.

  • |

    He Sued the Country, Settled with Himself, and Sent the Invoice to ‘Us.

    ByPhil McCracken

    A “settlement” is supposed to stop the bleeding, not turn it into a branded billing cycle. But in the pretend checklist it goes like this: TRUMP GETS FORMAL APOLOGY, PAST IRS AUDIT SHIELD, and a POLITICAL PAYOUT MACHINE with a tidy $1.176 BILLION line—and, naturally, MORE DONOR MYTHOLOGY.

    Then the other column taps the glass: TAXPAYERS GET THE BILL, HIGHER COSTS, WEAKER DEMOCRACY, and ZERO ACCOUNTABILITY. If they’re calling it accountability, it sure looks like accountability arrives as paperwork… delivered to us.

  • |

    Transparency Still Works Like a Paperwork Escape Room

    ByPhil McCracken

    I keep hearing Washington say “transparency” like it’s a universal solvent, but the Lobbying Disclosure Act feels less like a ledger and more like a paperwork escape room: you can fill out the forms and still not reach the accountability exit. Follow the invoice, sure—if the invoice came with missing pages and a help desk that answers in sunsets.

    GAO’s report GAO-26-108486 puts numbers on the vibes. It found potential non-disclosure issues in roughly 22% of LD-2 reports related to required “covered positions.” And on enforcement, GAO says the U.S. Attorney’s Office received 12,391 referrals for failure to file from 2016–2025, with only about 46% resolved as compliant by December 2025. That’s not “all clear, citizens”—that’s “the system is still processing your certainty.”

    This is where the revolving-door PR line starts selling a magic trick: if influence is disclosed, then influence is fully knowable. But GAO is describing a disclosure pipeline that depends on accurate “covered position” reporting and timely follow-through on failure-to-file referrals. When transparency depends on whether paperwork was correctly completed and whether referrals get resolved fast enough, the experience for ordinary taxpayers stops being legibility and starts being roulette with forms.

    So yes, transparency exists. But what the design really delivers is a choose-your-own-adventure version of governance—where the accountability ending depends on compliance quality, referral volume, and processing timelines rather than voter consent. If the public’s “read the receipts” plan comes with missing labels and an aging stack of unresolved referrals, don’t call it transparency; call it procurement jazz hands for the donor class—done in a broom closet labeled “public access.”

  • |

    Maybe the Problem Isn’t Technology—It’s the Waiting Room

    ByJustin Jest

    We can secure the part where everyone pretends it’s “just logistics”: encrypted, protected, tamper-proof, legally binding—verified, instant, identity confirmed. Then we get to laws, and suddenly it’s all “too complicated,” “not ready,” and “not how it works,” like your ballot is waiting in a legislative waiting room guarded by lobbyist/big-money influence.

    Maybe the problem isn’t technology. Maybe it’s the middlemen—because if democracy needs handlers, then “verification” becomes permission slips, and the delay just becomes a job benefit.

  • |

    They Want Your Vote, Not Your Invoice

    ByPhil McCracken

    I’m standing in TRUMP TOWER, watching the crowd chant “TRUMP SAVES AMERICA” like that’s a membership fee. Then the offer slides in: the future is MEMBERS ONLY, tucked on the TOP FLOOR with SPECIAL TREATMENT and NO WORK REQUIRED—and I’m just the tired constituent holding the receipt like, “They respect me?”

    Sure, the pitch comes wrapped in “we’re fighting for us,” but the billing arrives for “your anger” in their business model. When they cash in on your frustration, why do you keep calling it leadership?

  • |

    War’s Bill, Contracts’ Paycheck

    ByPhil McCracken

    Follow the invoice and the slogan starts cracking: “war for us” becomes kids, taxes, debt, underfunded veterans’ care, and families getting squeezed—while the other half of the ledger is defense contracting, framed like unavoidable “billions guaranteed.” The pitch is shared sacrifice; the receipts are selective comfort. Somewhere, “security” turns into a subscription plan with upsells for people who don’t have to carry the weight of the consequences.

    And that’s the part I can’t stop seeing on Capitol Hill: the country pays like it’s a community project, then procurement jazz hands the payout into someone else’s bank account. People pay the price. The connected profit. So whose “we” are we talking about—ours, or theirs?

End of content

End of content